1.Internal Reliability of Psychosocial Function Evaluation for Mental Disabilities
Li LUO ; Qiuwen ZHOU ; Min XUE ; Zhixun ZHANG ; Peiyan YU ; Chunhao DUAN ; Gang ZHENG ; Cenyan YU ; Shaojing ZHANG ; Gang CHEN
Chinese Journal of Rehabilitation Theory and Practice 2013;19(11):1074-1076
Objective To evaluate the internal reliability of Psychosocial Function Evaluation for mental disabled people in day care unit. Methods 16 participants were evaluated twice by the same rater (social worker) in the unit at the Permanent stage and the Steering stage. Results Cronbach's α was greater than 0.7 in the both evaluation. The Spearman correlation coefficient between each dimension and total score were between 0.502 and 0.869. Conclusion The internal reliability of Psychosocial Function Evaluation is satisfactory for mental disabilities.
2.Performance of Assistive Devices Program in Zhabei, Shanghai: A Brief Introduction
Min XUE ; Cenyan YU ; Li LUO ; Gang ZHENG ; Zhishun ZHANG ; Xiaoxiao SUN ; Peiyan YU ; Wenshu CAO ; Chunhao DUAN ; Shaojian ZHANG ; Gang CHEN
Chinese Journal of Rehabilitation Theory and Practice 2013;19(5):485-488
The Assistive Devices Program was funded and supported sufficiently, and improved the qulity of life of the disabled persons significantly (scores of SF-36). Most disabled users were satisfied with the Program. Some problems, such as inefficient way of working,undefined screening standards, lack of integrity of the assessment content, limited categories of assistive devices and home modifications,unavailable follow-up services, needed to be improved.
3.Cardiac/coronary artery lesion in Kawasaki disease treated with different kind of intravenous immunoglobulin therapy in Shanghai from 1998-2008
Lijian XIE ; Cenyan YU ; Xiaojin MA ; Shubao CHEN ; Rongfa WANG ; Meirong HUANG ; Zhongzhen GUO ; Jinjin JIANG ; Xiaoxun ZHOU ; Qing YU ; Dingzhong QIU ; Yonghao GUI ; Shoubao NING ; Min HUANG ; Guoying HUANG
Journal of Clinical Pediatrics 2009;(10):901-905
Objective To evaluate the effect of different kind of intravenous immunoglobulin (IVIG) therapy in treating Kawasaki disease (KD) and preventing cardiac consequences (coronary artery lesion, CAL). Methods A questionnaire form and guideline for KD diagnosis were sent to 50 hospitals providing pediatric medical care in Shanghai. The data from a total of 1 682 KD patients were collected. It included 1 064 males and 618 females from 1998 through 2008 in Shanghai. The average age of the KD patients was (2.57±2.33) years old (0.1-18.8 years).The patients had been divided into 6 groups for different IVIG therapy, which included 1 g/kg once, 2 g/kg once, 0.4-0.5 g/kg five times, 1 g/kg twice, 2 g/kg twice and others. SAS 6.12 software was used for statistical analysis. Results In all KD patients, the patients treated with IV1G in 5th-10th day of illness has the least cardiac complication and CAL incidence and the group with IVIG therapy of 1 g/kg twice also has the least cardiac complication and CAL incidence. Conclusions The best doses of IVIG in treating KD is 1 g/kg twice and the IVIG therapy should be used in 5th-10th day of KD illness.